Conor buys paclitaxel supplier for DES (drug-eluting stent)
This article was originally published in Clinica
Executive Summary
Conor Medsystems has purchased substantially all assets of its recently-bankrupt paclitaxel supplier Phytogen Life Sciences for $3.8m. Conor will record the transaction as an acquisition of assets.